Cathleen Lutz, PhD, Vice President of the Rare Disease Translational Center at The Jackson Laboratory (JAX), discusses how the laboratory is addressing unmet needs in rare diseases.
JAX aims to understand the underlying pathophysiologies of diseases and develop targeted therapeutics. Dr. Lutz describes just a few of the areas of rare diseases where needs are unmet, including: information, treatment, resources, and funding. From a developmental standpoint, regulatory guidelines can also impose challenges to developing new treatment options for rare diseases.
To learn more about rare diseases, visit https://checkrare.com/
